tiprankstipranks
Quantum Biopharma (TSE:QNTM)
:QNTM
Canadian Market

Quantum Biopharma (QNTM) Income Statement

Compare
62 Followers

Quantum Biopharma Income Statement

Last quarter (Q4 2023), Quantum Biopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Quantum Biopharma's net income was $―. See Quantum Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Aug 17
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ 4.54M$ 4.11M$ 3.90M$ ―
EBITDA
$ ―$ -22.57M$ -29.09M$ -24.46M$ -19.37K
Operating Income
$ -19.23M$ -27.48M$ -33.81M$ -30.69M$ -19.37K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -17.90M$ -23.61M$ -35.29M$ -31.80M$ -19.37K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Quantum Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis